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Summary The colorectal adenoma-carcinoma sequence was examined in relation to the ectopic expression
of the oncofoetal Small Intestinal Mucin Antigen (SIMA), to the development of morphologic changes in the
adenoma and perineoplastic mucosa and to indices of malignant potential. Four anti-SIMA MAbs, which
define a novel hierarchy of SIMA epitopes in the normal small intestine and adjacent to colorectal cancers,
were used in a retrospective immunohistochemical study of Familial Adenomatous Polyposis (FAP, n = 183)
and non-familial (n = 44) adenomas. Inappropriate expression of SIMA epitopes was first detected in mucosa
adjacent to minute microadenomas larger than three glands, and with increase in size, in increasing amounts
within adenomas themselves, but not with microadenomas smaller than three glands or regions of flat mucosa
free of adenomas. SIMA epitope expressed in mucosa adjacent to adenomas preceded changes in perineoplas-
tic morphology, which progressed with adenoma growth to resemble transitional mucosa (TM) adjacent to
cancers. Thus, the onset of both SIMA expression and morphological changes in TM were consistent with
reactive rather than pre-existing field change phenomena. The previously reported hierarchy of four SIMA
epitopes (5C5, 3D4, 4D3, 6C5) was also consistently observed in the adenoma-carcinoma sequence, and
applied to (i) the order of epitope detection, (ii) the number of positive adenomas and (iii) extent of staining;
(iv) the height in the crypt and (v) distance from the adenoma to which epitopes were expressed in
perineoplastic mucosa. These observations are consistent with a progression of changes in mucin composition
with adenoma development. The percentage of positive adenomas and reactivity scores for each anti-SIMA
MAb correlated with increasing adenoma size, degree of dysplasia and growth pattern. SIMA expression
appears to predate the earliest reported oncogene and tumour suppressor gene changes, was persistent and
increased throughout adenoma development. SIMA epitopes are thus markers of very early neoplastic change,
whose expression correlates with malignant potential and may contribute to the accumulation of changes
necessary for tumourigenesis.
The adenoma-carcinoma sequence in the colorectum is
strongly supported by epidemiological data (Enterline et al.,
1976; Hill et al., 1978), genetic studies (Cannon-Albright et
al., 1988), pathological data (Muto et al., 1975) and the
natural history of untreated familial and non-familial
adenomas (Jackman & Mayo, 1951; Stryker et al., 1987). The
progression from adenoma to carcinoma has been proposed
to be a multi-step process (Hill et al., 1978) and activation of
particular proto-oncogenes and inactivation of tumour supp-
ressor genes have recently been identified at particular stages
in the evolving adenoma (Fearon & Vogelstein, 1990).
Other important molecular changes associated with colo-
rectal neoplasia include alterations in mucin composition, not
only in cancers themselves (Feizi et al., 1984; Bara et al.,
1980; Hertzog et al., 1991a,b), but also in the adjacent,
non-neoplastic 'transitional mucosa' (TM) (Filipe, 1979; Bara
et al., 1984; Pilbrow et al., 1992a). It has been proposed that
TM represents a pre-existing field change (Filipe, 1979)
although other studies suggest a reactive change (Isaacson &
Attwood, 1979; Listinsky & Riddell, 1981). The former con-
tention has gained support from descriptions of similar mor-
phologic, histochemical and antigenic changes in premalig-
nant epithelium, namely ulcerative colitis (Podolsky et al.,
1983; Filipe et al., 1988), adenomatous polyps (Filipe et al.,
1980; Bara et al., 1983; Itzkowitz et al., 1986) and animal
models of colon carcinogenesis (Filipe, 1975; Decaens et al.,
1983). However, whether mucin and TM changes in the
human adenoma-carcinoma sequence represent a field change
or a reactive change remains controversial.
In previous studies from our laboratory, we have produced
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new MAbs to gastrointestinal mucins, SIMA (Small Intes-
tinal Mucin Antigen), and LIMA (Large Intestinal Mucin
Antigen). SIMA, an oncofoetal antigen of the colon, distinct
from the normal colonic antigen LIMA, is a high molecular
weight mucin glycoprotein with repeating epitopes, expressed
inappropriately in 94% colorectal cancers (Hertzog et al.,
1991a,b). Using a panel of four anti-SIMA MAbs (5C5, 3D4,
4D3 and 6C5), we recently demonstrated a novel hierarchy of
epitope expression in the normal small intestine villus, which
was reexpressed in TM crypts adjacent to colorectal cancers
(Pilbrow et al., 1992a). A comparable hierarchy of three
LIMA epitopes in the normal colon crypt has also been
reported (Pilbrow et al., 1992b). In a study which mapped the
extent ofchanges in Swiss Roll preparations of perineoplastic
mucosa around colorectal cancers, SIMA was detected in
adjacent TM in 15/15 cases, and in distant morphologically
normal mucosa at the resection margins in 11/15 cases (Pil-
brow et al., 1992a). Whether such epithelial changes were
pre-existing or reactive to the cancer was unknown. In order
to address this question, we have used this same panel of
four anti-SIMA MAb to examine changes in mucin composi-
tion and perineoplastic morphology in the human adenoma-
carcinoma sequence using adenomas of a wide range of sizes.
degree ofdysplasia and growth pattern, three well-established
indices of malignant potential (Muto et al., 1975).
Materials and methods
Source oftissue specimens and clinical information
Retrospective paraffin blocks and/or newly resected adenoma
specimens were obtained, including where possible, several
cm of adjacent mucosa. Small and large intestinal specimens
from patients free of GI tract disease were used as positive/
negative tissue controls. Pathologist's reports detailing size,
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degree of dysplasia and growth pattern accompanied each
specimen:
(i) FAP (nine patients, 208 adenomas, Table I) Two were
male, seven female, mean age 23.9 (range 15-40). Adenomas
were from sites throughout each colectomy specimen, in most
cases unspecified. Two patients had a synchronous cancer.
(ii) Non-familial adenomas (32 patients, 44 adenomas, Table
I) Ten patients were male (mean age 61.2, range 43-73),
ten female (mean age 66.8, range 59-77), and 12 of un-
specified age and sex. Anatomical sites were caecum (2), asc.
colon (9), hep. flexure (2), trans. colon (2), desc. colon (2),
sigmoid (5), rectum (7), unspecified (15). Six cases had syn-
chronous cancer; one had ulcerative colitis.
(iii) Metaplastic polyps (ten patients, 27 polyps) These
included five male, five female (mean age 66.3, range 57-87).
Three patients had synchronous colorectal cancers, one of
whom had 13 metaplastic polyps. (Additional polyps within
the TM zones of the cancers were excluded).
Histopathology
Specimens were fixed in phosphate buffered formalin,
paraffin-embedded, and cut into serial 5plm sections. One
section per block was routinely stained using the Alcian Blue
(pH2.5)/periodic acid-Schiff/Mayer's Haematoxylin stain,
projected at a 10 x magnification and tissues outlined.
Adenomas were identified, and dimensions measured. From
these, and in larger cases, from dimensions in the patho-
logists' reports, approximate cross-sectional area (length x
height) (Goh and Jass, 1987) was calculated for each
adenoma, and thereby grouped into semi-log sizes (<0.1
mm2, 0.1-0.3 mm2,0.3-1.Omm2, . . . 3,000-10,000 mm2,
Table I). In the three smallest size groupings, adenoma
dimensions were measured using a stage micrometer, and the
cross-sectional number of glands in each adenoma was
counted for comparison with surface area [<0.1 mm2: 1-4
glands, median three glands (n = ten adenomas);
0.1-0.3 mm2: 3-18 glands, median seven glands (n = 21);
0.3-1.0 mm2: 9-42 glands, median 20 (n = 37)]. Assessments
were made of degree of dysplasia (mild, moderate, severe)
and growth pattern (tubular, tubulovillous, villous) by author
SJP according to current WHO criteria (Jass & Sobin, 1989).
Table I Classification of adenomas to
pattern by numbe
Adenomas of both groups were of similar morphology,
although those from the younger FAP group were predom-
inantly smaller, less dysplastic and more tubular than the
non-familial adenomas (generally larger, mor dysplastic,
greater villous component). In both groups the degree of
dysplasia and growth pattern were partly related to size
(Table I). Finally, zones of altered morphology in adjacent
mucosa were characterised. 25/208 FAP microadenomas
identified within the 'shadow' of abnormal mucosa adjacent
to larger adenomas were excluded from the study, leaving
183 'independent' adenomas.
Monoclonal antibodies
The production, immunochemical and immunohistochemical
characterisation of the MAbs used in this study have been
described previously. Anti-SIMA MAb 4D3 and anti-LIMA
MAb 2C3 were prepared by immunisation of mice with a
mucin extract from a colorectal cancer (Hertzog et al., 1991a
and b), and anti-SIMA MAb 3D4, 5C5 and 6C5 by
immunisation with a mucin extract of post-mortem tissue
from normal adult small intestine (Pilbrow et al., 1992a).
Hybridoma supernatants were stored frozen at -20°C, and
thawed at room temperature immediately prior to use. All
four anti-SIMA MAbs were shown previously to be
neuraminidase- and periodate-sensitive, and to recognise
different epitopes in ELISA and immunohistochemical
studies, distinct from Sialosyl-Tn (MAb TKH2). MAb
isotypes were IgG3/K [4D3]; IgG1/K [6C5,2C3]; IgM/K
[3D4,5C5] (Hertzog et al., 1991a; Pilbrow et al., 1992a).
Immunohistochemistry
Consecutive 5 1tm sections of each block were dewaxed,
reacted with each of the five MAbs, stained by an indirect
immunoperoxidase technique (Hertzog et al., 1991a), and
counterstained with Haematoxylin. Working dilutions for
each of the primary and secondary antibodies were estab-
lished by checkerboard titrations using normal colon and
small intestinal tissue controls. Horseradish peroxidase
(HRP)-conjugated rabbit anti-mouse immunoglobulin (Ig)
was obtained from Dakopatts (Denmark).
For each MAb, a qualitative assessment of the
predominant cellular staining patterns was made. For each
adenoma, reactivity patterns of the five MAb were recorded
size, degree of dysplasia and growth
er of adenomas
Tubular Tubulovillous Villous
Mild Mod Sev Mild Mod Sev Mild Mod Sev Total
Area (mm2)
<0.3 32 32
1 1
0.3-1.0 36 1 37
0
1.0-3.0 39 2 41
0 3
3.0-10 26 8 34
3 1 1 5
10-30 7 7 3 1 18
1 1 1 1 4
30-100 1 8 1 3 2 1 16
1 1 2 1 1 6
100-300 1 2 1 4
1 1 4 1 1 4 2 14
300-1000 1
1 1 1 3 1 1 7
>1000 0
1 1 2 4
Total 141 28 6 5 2 1 183
8 4 2 7 6 4 1 8 4 44
Key: FAP, bold type, upper line; Non-familial adenomas, normal type, lower line,
Degree of dysplasia [mild, mod (moderate), sev (severe)]; growth pattern [tubular,
tubulovillous, villous]; size (surface area mm2].750 S.J. PILBROW
in three areas where present: neoplastic adenoma tissue, base
of adenoma and immediately adjacent perineoplastic mucosa.
A previously described scoring method was used: a score of
0-3 was given for staining intensity and similarly, for dist-
ribution [0 (negative, 1 (<25% of crypt positive), 2
(25-75%) or 3 (75-100%)]. Aggregate scores (0-6) were
obtained by adding the two scores (Hertzog et al.,
1991b).
Data analysis
Univariate correlations were made between each individual
MAb reactivity (whether positive or negative; and reactivity
scores) in the adenoma, base and adjacent mucosa and the
three indices of malignant potential: size (surface area),
degree of dysplasia and growth pattern, for both FAP and
non-familial groups. Scores were expressed as mean ± stan-
dard error of mean (SEM) as a measure of variance of these
scores in our patient population. Perineoplastic mor-
phological zones were also correlated with adenoma size.
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Results
A. Qualitative immunohistochemical reactivitypatterns
(i) SIMA expression in the developing adenoma
In the smallest, single gland microadenomas, there were
generally no SIMA epitopes expressed at all (Figure la). In
microadenomas greater than approximately three glands in
size, traces of SIMA were identified adjacent to but not in
the actual neoplastic adenoma glands. With increasing size,
SIMA expression was more prominent at the base of the
adenoma and in the immediately adjacent perineoplastic
mucosa, and detectable in neoplastic adenoma glands (Figure
lb and lc). With larger adenomas, SIMA was expressed to
an increasingly greater extent in the neoplastic adenoma
glands, beginning in the inner, least dysplastic areas (Figure
ld), and eventually involving the entire adenoma, including
distal villous areas (Figure le) and the most severely dysplas-
tic areas (Figure 0f). Specific patterns of individual epitopes
are discussed in detail below (section A(iv)). Similar to
b c
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Figure 1 Immunoperoxidase staining of sections of adenomas at various stages in development with anti-SIMA MAb 4D3: a, a
single gland microadenoma (arrow) showing no reactivity (original magn. x 25); b, a larger microadenoma showing patchy goblet
cell and secreted mucin reactivity in non-neoplastic glands within the substance of the adenoma (arrow) and at the base and in
adjacent mucosa (arrowheads) (original magn. x 10). In larger adenomas, strong staining is shown both c, at the base of the
adenoma (goblet cells, arrow) (original magn. x 25) and d, within neoplastic glands of adenoma (goblet cells, arrow) (original
magn. x 25) e, the outer tip of a villous adenoma (goblet cells, arrow) (original magn. x 25), and f, a severely dysplastic area of a
very large adenoma (secreted mucin, arrow) (original magn. x 25).
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previous studies, the normal colonic anti-LIMA MAb 2C3
reacted with adenomas from the smallest (SIMA-negative)
microadenomas to quite large adenomas, including areas
which were expressing SIMA epitopes (Pilbrow et al.,
1992b).
(ii) Localisation at the cellular level In and adjacent to
adenomas, each anti-SIMA MAb reacted with goblet cell
(GC) and extracellular secreted mucin (Figure 3a); these are
the same cellular compartments as previously reported for
normal small intestine, colorectal cancer and adjacent TM
(Hertzog et al., 1991a,b; Pilbrow et al., 1992a). Each anti-
SIMA MAb reacted also with mucinous lakes in large
adenomas, and in some cases, with serum in submucosal
blood vessels. Anti-LIMA MAb 2C3 reacted with GCs and
extracellular mucin in small to moderately-sized adenomas,
similar to normal colon; with increasing adenoma size, ext-
racellular mucin staining persisted, apical staining became
more prominent, and GC reactivity diminished, resembling
its pattern in cancers (Pilbrow et al., 1992b).
(iii) Crypt localisation In smaller adenomas, anti-SIMA
MAb reactivity was strongest at the base of the dysplastic
'crypts' (the innermost part) of adenomas (Figure lb), and in
the lower crypt of the perineoplastic mucosa (Figure 2a). In
larger adenomas, anti-SIMA reactivity was increasingly
widespread throughout the adenomas (Figure ld) and to a
greater height in the crypt of the immediately adjacent
mucosa (Figure 2b), but reducing to a lower portion of the
crypt with increasing distance; this was similar to the pattern
adjacent to cancers (Pilbrow et al., 1992a). Anti-LIMA MAb
2C3 was generally reactive throughout smaller adenomas and
their perineoplastic mucosa; within larger adenomas, it
reacted more patchily throughout but remained strongly
reactive in perineoplastic crypts.
(iv) Comparison between individual anti-SIMA MAbs (Figure
3) Most of the smallest microadenomas expressed no
SIMA epitopes, although some expressed the 5C5 epitope. With increase in adenoma size, additional epitopes were
detected in a consistent sequence: the pattern of 'recruitment'
of epitopes detected appeared to be 5C5, 5C5 + 3D4,
5C5 + 3D4 + 4D3, and eventually 5C5 + 3D4 + 4D3 + 6C5
in large adenomas. Alternative combinations were rare, and
6C5 was essentially only expressed in adenomas which also
expressed the other three SIMA epitopes. Each MAb fol-
lowed the same apparent order of tissue localisation with
increase in adenoma size: base, adjacent, inner core of
adenoma, throughout adenoma, although MAb 5C5 showed
more prominent reactivity with actual adenoma glands in
microadenomas.
B. Semi-quantitative andclinicopathological correlations
(i)- Percentage of positive adenomas The percentage of
adenomas reactive with each anti-SIMA MAb correlated
with each of the three indices of malignant potential:
increasing size (Figure 4), degree of dysplasia (Figure 5) and
progression from tubular to villous growth pattern (Figure
6). Throughout most size ranges, three of the anti-SIMA
MAbs (4D3, 3D4 and 6C5) were more frequently reactive in
the base of the adenoma than in the adjacent tissue and least
in the actual adenoma. This was most apparent in the size
ranges from the 0.3-1.0 mm2 range (9-42 glands, median 20
glands, n = 37) to the 10-30mm2 range (Figure 4). In
contrast, MAb 5C5 generally showed prominent reactivity at
all sizes in both the adenoma, base and adjacent mucosa,
even the smallest ones. In adenomas with a cross-sectional
area ofgreater than 100 mm2 (i.e. diameter > 1 cm), 100% of
FAP adenomas reacted with all anti-SIMA MAbs (Figure 4).
For each index, 5C5 was the most frequently detected in
lower grades ofmalignant potential (small, mildly dysplastic,
tubular), followed by 3D4, 4D3 and 6C5; in the highest
grades (large, severely dysplastic, villous) all 4 epitopes were
detected. Nonfamilial adenomas showed similar correlations
between SIMA epitopes and indices of malignant potential
(Figure 5). SIMA showed no association with local
Flgure 2 Immunoperoxidase staining of MAb 4D3 in perineoplastic mucosa: a, adjacent to small adenomas, in lower 1/3 of crypt and b, adjacent to large adenomas throughout crypt (goblet cells, arrows) (original magn. x 25).752 S.J. PILBROW
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Figure 3 Comparison between immunohistochemical reactivities of four anti-SIMA MAbs in a small pedunculated adenoma (a-d) and its perineoplastic mucosa (e-h): 5C5 (a and e), expressed to the greatest extent in the adenoma and to the greatest distance from the adenoma; 3D4 (b and f) and 4D3 (c and g) expressed strongly at the base of the adenoma, and a short distance into the perineoplastic mucosa, 6C5 (d and h) expressed to a limited extent at the base only (original magnifications x 10).
inflammatory changes, which were observed only in relation
to larger adenomas.
(ii) Staining intensity and distribution As a
semi-quantitative measure of SIMA expression per unit area
of tissue, mean reactivity scores (0-6) for each MAb were
shown to correlate with size, dysplasia and growth pattern.
Mean scores (± SEM) for MAbs 5C5 and 6C5 vs size are
shown (Figure 7). Notably, MAb 6C5 showed only trace
amounts until the 10-30 mm2 size range, while MAb 5C5
reacted at much smaller sizes (<0.1 mm2, approx. 3-4
glands).
C. Perineoplastic mucosa
(i) Description of morphological zones Five zones of
perineoplastic mucosa were identified from marked atypia to
morphologically normal mucosa (MNM), with features
comparable to TM zones around colorectal cancers (Pilbrow
et al., 1992a): TM-I, a very small zone of few small GCs and
many columnar cells at the adenoma base (Figure 8a);
TM-I1, elongated, dilated and branched crypts, croweded
with large goblet cells (GC) (Figure 8b); Zone III, crypts of
normal height but dilated and with enlarged GCs (Figure 8c);
Zone IV, patchy crypt dilatation and scattered large GCs
interspersed with normal colorectal morphology; and MNM
(Figure 8d).
(ii) Relationship between morphological zones and adenoma
size Zones of increasing atypia, as defined above, appeared
to be sequentially acquired with increasing FAP adenoma
size (Figure 9). The smallest microadenomas (<0.1 mm2, 1-4
glands; median 3)] were all surrounded by MNM only.
However, in the 0.1-0.3 mm2 range (3-18 glands; median 7),
53% showed minor TM changes (zone IV, 48%; zone III,
5%), and in the 0.3-1.0 mm2 range (9-42 glands; median
20), 81% (zone IV, 32%; zone III, 49%). At each size, the
most atypical zone was innermost, frequently interdigitatingMUCINS IN ADENOMA-CARCINOMA SEQUENCE 753
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Figure 6 Percentage of FAP adenomas reacting with all four
anti-SIMA MAbs as a function of pattern of growth.
Figure 4 Percentage of FAP adenomas reacting with anti-SIMA
MAbs as a function of size (surface area) in adenoma, base and
adjacent mucosa: a, 5C5 b, 3D4 c, 4D3 and d, 6C5.
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Figure 5 Percentage of adenomas reacting with anti-SIMA
MAbs 5C5 and 6C5 as a function of degree of dysplasia: com-
parison of FAP and non-familial adenomas.
with the adenoma, followed by concentric zones of
diminishing atypia (e.g. adenoma, III, IV, MNM) similar to
TM ofcolorectal cancers (Pilbrow et al., 1992a). Zone I, only
several crypts wide around cancers, was found only in
isolated patches at the adenoma-perineoplastic interface of
large adenomas. The length of each zone and the total length
of TM increased with adenoma size, and appeared
symmetrical proximal and distal to each adenoma.
Most non-familial adenomas showed TM changes similar
to the FAP group, although, due to the more limited size
range, the changes with increase in size were less clearly
o 0
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Figure 7 Semiquantitative correlation of anti-SIMA MAb 5C5
and 6C5 reactivity scores (0-6) with adenoma size. Data are
presented as mean ± S.E.M.
demonstrable. In addition, 5/17 of the adenomas > 100 mm2
showed submaximal TM changes .
(iii) Expression of SIMA in perineoplastic zones (Figure 8).
With increase in adenoma size, SIMA expression in
perineoplastic mucosa increased in intensity and was
observed to a greater distance from the adenoma, and
appeared symmetrical proximal and distal to each adenoma;
in relation to the largest adenomas this resembled SIMA
expression in TM adjacent to colorectal cancers. The
maximum intensity for each adenoma was in the most
atypical TM closest to the adenoma, but the intensity and
extent of SIMA expression for a given zone and size of
adenoma varied from one patient to another. When two
adenomas were located close together, their SIMA-reactive
zones sometimes overlapped (particularly with MAb 5C5,
rarely with 6C5); when spaced widely apart, there were
lengths of mucosa in between which did not express SIMA.
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Figure 8 Immunoperoxidase staining of perineoplastic mucosa zones adjacent to adenomas, using anti-SIMA MAb 5C5 a, TM-I
with scanty small, unreactive GCs and mostly columnar cells (arrows), adjacent adenoma tissue (arrowhead); b, TM-II (tall,
reactive goblet cells, arrow; dilated, mucin-filled crypt lumina, arrowhead); c, zone III with large, reactive goblet cells (arrow), less
dilated crypts, and d, morphologically normal mucosa (MNM) with reactive GCs (arrow). (Original magnifications x 25).
There was frequently overlap of reactivity in GCs of the
lower and middle crypt between the normal anti-LIMA MAb
2C3 and anti-SIMA MAbs.
In the cases where sufficient perineoplastic mucosa were
available, the maximum distances to which each epitope was
detected were measured. The most frequent pattern, seen in
17/24 FAP and 18/24 non-familial adenomas (see example in
Figure 3), was that MAb 5C5 reacted to the longest distance
(17cm in one case), followed by 3D4 and 4D3, and least,
6C5, as observed with distance from cancers (Pilbrow et al.,
1992a). The mean ratios of maximum distance for each MAb
to that of 5C5 in the 17 FAP adenomas showing this order
were: 3D4/5C5, 0.64; 4D3/5C5, 0.64; 6C5/5C5, 0.23.
Metaplastic polyps
Of 27 metaplastic polyps (ranging from 0.25 to 100 mm2 in
area, mostly <1Omm2), trace amounts or more of SIMA
epitopes were detected in GC/secreted mucin by MAb 5C5
(30% polyps: 0/13 from one patient, 8/14 remaining polyps),
3D4 (67%), 4D3 (52%), 6C5 (44%); 100% were LIMA (2C3)
positive. In this small study, no trends were observed with
respect to polyp size, nor differences between cancer- and
non-cancer-bearing cases.
Discussion
SIMA, an oncofoetal antigen for the colon, is established
here as a marker of very early neoplastic change in the
colorectum, common to both FAP and non-familial
adenomas. By examining a more complete spectrum of
adenoma size than in other studies to date, we were able to
identify 4 SIMA epitopes in adenomas at earlier stages than
studies of genetic changes (Fearon & Vogelstein, 1990) and
altered expression of other mucin antigens (Zotter et al.,
1987; Wolf et al., 1989). Altered SIMA expression com-
mences before changes in perineoplastic morphology [transi-
tional mucosa (TM)]; both changes follow microadenoma
formation, evolve with adenoma development, and eventuallyMUCINS IN ADENOMA-CARCINOMA SEQUENCE 755
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Figure 9 The acquisition of morphological changes in perineop-
lastic mucosa with increase in size of FAP adenomas. Stacked
bar graph shows maximum degree of morphological atypia
observed in the immediate perineoplastic mucosa, as a relative
percentage of adenomas, for each size range.
resemble those associated with colorectal cancer. We have
further identified a differentiation-associated hierarchy of
SIMA epitopes (Pilbrow et al., 1992a) during the adenoma-
carcinoma sequence, whose expression correlates with indices
of malignant potential.
The adenoma-carcinoma sequence has recently been shown
to be associated with the accumulation of specific genetic
alterations: ras oncogene mutations, and allelic deletions of
the 5q, 18q and 17p chromosomal regions proposed to con-
tain tumour suppressor genes, such as the p53 gene (17p)
(Fearon & Vogelstein, 1990) and the APC gene (5q21,
Hoshino et al., 1991). FAP patients have inherited mutations
in the APC gene (5q21) (Groden et al., 1991; Nishisho et al.,
1991); these can be detected in their polyps, whereas allelic
losses of 5q have been described only in non-familial
adenomas (only 3/8 <1 cm length adenomas, smallest 5 mm;
Vogelstein et al., 1988). The other genetic alterations how-
ever, are associated with more advanced adenomas: ras
mutations with increasing size, villous pattern and dysplasia,
and losses of 18q and 17p with advanced adenomas and
malignant change respectively (Vogelstein et al., 1988; Purdie
et al., 1991). However, our study of SIMA expression
indicates that, over four orders of magnitude of surface area
from 0.01 mm2 (1-gland) microadenomas to 100 mm2 (approx.
1 cm length) adenomas, additional events may be occurring.
SIMA epitopes begin to be expressed in association with
minute microadenomas (approximately 3-gland size), with the
number of adenomas and quantitative SIMA reactivity in-
creasing steadily with adenoma growth, their ordered
appearance indicating a series of changes (see below).
Moreover, at the 100 mm2 size, when ras mutations and Sq
deletions are still uncommon (Vogelstein et al., 1988), all four
SIMA epitopes are almost unversally expressed in adenomas
of both groups. Furthermore, they continue to be highly
expressed in cancers (Pilbrow et al., 1992a). SIMA expression
thus appears to be a very early and persistent change in the
adenoma-carcinoma sequence, reflecting changes in
differentiation, and which may itself contribute to the
changes necessary for malignant change. By contrast, we
have shown that the expression of normal colonic mucin
(LIMA) epitopes, while prominent in GCs of small
adenomas, decreases with increasing adenoma size (Pilbrow
et al., 1992b).
There was no field change predating the development of a
tumour according to SIMA detection or morphological
criteria. Trace amounts of SIMA were first noted at the base
of the crypt of non-neoplastic MNM adjacent to very small
microadenomas, later in the actual adenoma. This suggests
that SIMA expression is a reactive change, possibly due to a
factor secreted by the adenoma, exerting a paracrine effect
initially on adjacent non-neoplastic cells but not on the
tumour itself. Alternatively, a factor may be produced in a
host response to the tumour. The detection of SIMA in
increasingly peripheral regions of the adenoma with increase
in size was similar to its detection in increasingly higher levels
of the crypt in adjacent mucosa. This may reflect the upward
expansion of the basal proliferative zone (Deschner, 1990),
and the persistence of immature cells higher in the crypt and
eventual loss of crypt polarity with adenoma development
(Filipe, 1979).
The observation of the same order of SIMA epitopes (5C5,
3D4, 4D3, 6C5), as previously observed in normal small
intestine and adjacent to cancers (Pilbrow et al., 1992a),
during adenoma progression, suggested a consistent order of
changes in mucin composition. This applied to (i) the order
in which SIMA epitopes first appeared adjacent to mic-
roadenomas; (ii) the number of positive adenomas
<100 mm2 size; (iii) the order in which epitopes were initially
detected in microadenomas and later, the expansion of their
expression throughout the adenoma, and (iv) the height in
the colonic crypt and (v) maximum distance of expression in
the perineoplastic mucosa, similar to the pattern observed
around cancers (Pilbrow et al., 1992a).
These results suggest that the small intestinal mucin
phenotype we have previously observed in colorectal cancers
is acquired gradually in the developing adenoma, in a
similarly coordinated and sequential manner that reflects nor-
mal small intestinal enterocyte differentiation and crypt-villus
relationships; this may represent a form of metaplasia
(Agawa & Jass, 1990). In terms ofepitope structure, previous
studies have shown that the four anti-SIMA MAbs recognise
distinct neuraminidase-sensitive carbohydrate epitopes, two
which are distinct from sialosyl-Tn and 2 which partially
cross-react (Hertzog et al., 1991a; Pilbrow et al., 1992a).
Additive ELISAs have suggested that MAb 4D3 recognises a
core carbohydrate structure, and the other three MAbs, more
peripheral epitopes (Pilbrow et al., 1992a). Precise charac-
terisation of the epitopes is currently in progress.
While prospective studies show that only a minority of
adenomas will ultimately undergo malignant change (Stryker
et al., 1987), three predictive indices of malignant potential
are now well-established (Muto et al., 1975). In the present
study, SIMA expression, both in terms of numbers of
positive adenomas and amount of epitope expressed, cor-
related positively with each of the three indices. Correlations
have previously been reported between indices of malignant
potential and altered expression of various blood group-
related carbohydrate epitopes. Studies have reported normal
proximal colon antigens reemerging in distal adenomas (Itz-
kowitz et al., 1986), normal colonic antigens in inappropriate
crypt and cell compartments (Ruggerio et al., 1988), precur-
sor accumulations (Cooper & Reuter, 1983) and neosynthesis
of antigens (Kim et al., 1986). The majority of these show
altered or neo-expression late in adenoma development, in
contrast to SIMA epitopes, however none has been examined
systematically in minute adenomas to more precisely identify
the onset of altered expression. Of neoexpressed mucin
antigens, Ml was associated with villous (87%) more than
tubular (55%) adenomas (Bara et al., 1983), and MAM-6
(Zotter et al., 1987) and TAG-72 (Wolf et al., 1989) were
only associated with severe dysplasia, thus also reflecting late
changes.
The SIMA reactivity noted with serum in submucosal
blood vessels of several larger adenomas suggests that at a
particular stage of development, SIMA is released into the
circulation. As several SIMA epitopes can be detected in sera
of colorectal cancer patients (unpublished data), future ret-
rospective and prospective studies will investigate at what
stage SIMA is detectable in sera of adenoma patients and
hence its potential clinical value.
Of interest was the fact that SIMA was also detected in
metaplastic polyps, although no trends with respect to polyp756 S.J. PILBROW
size or synchronous colorectal cancer were observed.
Notably, other oncofoetal antigens of the colon including
T-antigen (Boland, 1987) have also been found in metaplastic
polyps. While metaplastic polyps were long regarded as
unrelated to neoplasia, recent evidence suggests clinically
important associations with colorectal cancer (Jass, 1983;
Teoh et al., 1989; Foutch et al., 1991), which may be
reflected in common mucin biosynthetic/degradative path-
ways.
In addition to changes in mucin expression, significant
observations were also made concerning the evolution of
perineoplastic morphology during the adenoma development.
The mucosa adjacent to adenomas has previously been noted
to be similar histologically and histochemically to TM
adjacent to cancers (Listinsky & Riddell, 1981; Filipe et al.,
1980), but whether it represents a pre-existing field change or
a reactive change has remained controversial. Many studies
of TM have been limited by technical problems and
non-specificity of histochemical techniques, and varying
definitions of TM morphology (Mughal & Filipe, 1978;
Greaves et al., 1984; Sugihara & Jass, 1987). Studies have
also been limited by narrow ranges of adenoma size:
predominantly large (Greaves et al., 1984) or small (approx
20-gland; Schmidbauer & Heilmann, 1980), or unspecified
size (Ruggerio et al., 1988). The present study describes the
sequential development of TM adjacent to adenomas over a
wide range of sizes. Notably, TM changes were shown not to
be a pre-existing field change, but to commence after mic-
roadenoma formation, at approximately a 7-gland size, and
to evolve as concentric zones ofincreasing atypia.
The intensity of SIMA expression was greatest in the most
atypical perineoplastic zones nearest the adenoma, lessening
with increasing distance and decreasing morphological
atypia, and absent in the morphologically normal flat mucosa
between widely-spaced small adenomas. This failure to find
SIMA expression in flat mucosa is in agreement with studies
which found normal glycosyltransferase levels in flat mucosa
of FAP patients (Slomski et al., 1986) and some
histochemical studies (Sugihara & Jass, 1987) but not others
(Filipe et al., 1980). This appears to be further evidence that
mucin and perineoplastic morphological changes are only
observed in relation to pre-existing adenomas. The present
study would thus appear to have settled the longstanding
debate: 'transitional mucosa: premalignant or reactive?' by
identifying that altered mucin expression and TM
morphological changes followed microadenoma formation,
and are thus consistent with reactive change.
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